- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma
Browse
Administrators only